← All Mink Therapeutics, INC filings

Mink Therapeutics, INC Form 4 insider transactions

NASDAQ
INKT
Mink Therapeutics, INC
Form 4: MiNK Therapeutics Director Peter Behner Acquires Shares and RSUs
Director Peter Behner acquired shares and restricted stock units (RSUs) of MiNK Therapeutics, Inc. on March 1, 2024.
NASDAQ
INKT
Mink Therapeutics, INC
Form 4: MiNK Therapeutics Director Barbara Ryan Reports Acquisition and Disposal of Common Stock
Director Barbara Ryan reported acquiring 18,685 shares of MiNK Therapeutics common stock at $0.95 per share and disposing of 86,617 shares on March 1, 2024.
NASDAQ
INKT
Mink Therapeutics, INC
Form 4: Mink Therapeutics Director Ulf Wiinberg Acquires Shares and Holds RSUs
Director Ulf Wiinberg reports acquisition of Mink Therapeutics shares and holding of restricted stock units (RSUs) in a recent SEC filing.
NASDAQ
INKT
Mink Therapeutics, INC
Form 4: Mink Therapeutics Director Brian Corvese Acquires Shares in Lieu of Cash Compensation
Director Brian Corvese acquired 18,816 shares of Mink Therapeutics common stock at $0.95 per share in lieu of cash retainers for board and committee compensation.